COCP Cocrystal Pharma, Inc.
Nasdaq · SEC CIK 1412486 · EDGAR
- Bought, last 12 months
- $300.6K 9 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 54 since 2021-07-20, latest 2026-08-06 17:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| FROST PHILLIP MD ET AL | Dir, 10% | $300.6K | — |
| Martin James Joseph | CFO, Co-CEO | — | — |
| PFENNIGER RICHARD C JR | Dir | — | — |
| Hassan Fred | Dir | — | — |
Transactions 23
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-06 17:11 | 2026-08-05 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.9816 | +10.0K | 1.99M | +0.5% | +$9,816 |
| I | 2026-08-05 16:10 | 2026-08-03 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.9412 | +75.0K | 1.98M | +4% | +$70.6K |
| I | 2026-02-25 | 2026-02-24 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $1.00 | +20.0K | 1.91M | +1% | +$20.0K |
| I | 2026-02-09 | 2026-02-06 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.95 | +50.0K | 1.89M | +3% | +$47.5K |
| I | 2026-01-02 | 2025-12-31 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.95 | +50.0K | 1.84M | +3% | +$47.5K |
| I | 2025-12-31 | 2025-12-30 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.97 | +20.0K | 1.79M | +1% | +$19.4K |
| MI | 2025-12-29 | 2025-12-24+ | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.97 | +65.0K | 1.77M | +4% | +$63.0K |
| MI | 2025-11-28 | 2025-11-26 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.9938 | +4,000 | 1.70M | +0.2% | +$3,975 |
| I | 2025-11-25 | 2025-11-25 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.94 | +20.0K | 1.70M | +1% | +$18.8K |
| D | 2025-10-30 | 2025-10-28 | COCP | Martin James Joseph | CFO, Co-CEO | A - Grant | $1.39 | +3,598 | 44.2K | +9% | +$5,001 |
| D | 2025-10-30 | 2025-10-28 | COCP | Hassan Fred | Dir | A - Grant | $1.39 | +359.7K | 1.38M | +35% | +$500.0K |
| D | 2025-10-30 | 2025-10-28 | COCP | PFENNIGER RICHARD C JR | Dir | A - Grant | — | +20.0K | 31.4K | +175% | — |
| DI | 2025-10-30 | 2025-10-28 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | A - Grant | $1.39 | +359.7K | 1.68M | +27% | +$500.0K |
| 2024-10-11 | 2024-10-09 | COCP | PFENNIGER RICHARD C JR | Dir | A - Grant | — | +8,067 | 11.4K | +242% | — | |
| 2024-10-11 | 2024-10-09 | COCP | Japour Anthony J | Dir | A - Grant | — | +14.9K | 14.9K | New | — | |
| 2024-10-11 | 2024-10-09 | COCP | Kornberg Roger D. | Dir | A - Grant | — | +28.1K | 28.1K | New | — | |
| 2024-10-11 | 2024-10-09 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | A - Grant | — | +27.1K | 27.1K | New | — | |
| 2024-10-11 | 2024-10-09 | COCP | Rubin Steven D | Dir | A - Grant | — | +19.0K | 2.66M | +0.7% | — | |
| 2024-10-11 | 2024-10-09 | COCP | Hassan Fred | Dir | A - Grant | — | +8,067 | 1.02M | +0.8% | — | |
| 2024-10-11 | 2024-10-09 | COCP | Martin James Joseph | CFO, Co-CEO | A - Grant | — | +40.0K | 40.6K | +7,030% | — | |
| 2024-10-11 | 2024-10-09 | COCP | Lee Sam | Pres, Co-CEO | A - Grant | — | +40.0K | 76.4K | +110% | — | |
| I | 2023-04-06 | 2023-04-04 | COCP | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $1.97 | +1.02M | 1.32M | +333% | +$2.00M |
| 2021-08-23 | 2021-08-20 | COCP | PFENNIGER RICHARD C JR | Dir | P - Purchase | $1.03 | +40.0K | 40.0K | New | +$41.2K |